Showing results (1491-1500 of 9,125) with videos related to

Sort By:
Pageof 913
Cancer Medicine|June 13, 2020
Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysisDi Jin, Kun Jin, Shi Qiu, et al.
Cancer Medicine|June 13, 2020
Effects of adaptive immune cell therapy on the immune cell profile in patients with advanced gastric cancerMiyabi Miura, Eishiro Mizukoshi, Tomomi Hashiba, et al.
Cancer Medicine|June 13, 2020
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter DatabaseMohammed A Alghamdi, Carla P Amaro, Richard Lee-Ying, et al.
Cancer Medicine|June 3, 2020
Galangin promotes cell apoptosis through suppression of H19 expression in hepatocellular carcinoma cellsXiaowei Zhong, Siyi Huang, Dianfeng Liu, et al.
Cancer Medicine|June 24, 2020
Racial and ethnic disparities in mortality from gastric and esophageal adenocarcinomaMonika Laszkowska, Angela C Tramontano, Judith Kim, et al.
Cancer Medicine|May 23, 2020
Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patientsTakashi Matsuki, Isaku Okamoto, Chihiro Fushimi, et al.
Cancer Medicine|May 22, 2020
HIF-1α interacts with Kindlin-2 and influences breast cancer elasticity: A study based on shear wave elastography imagingXiaowei Xue, Shaowei Xue, Wenbo Wan, et al.
Cancer Medicine|May 22, 2020
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessmentLucia Nogova, Christian Mattonet, Matthias Scheffler, et al.
Cancer Medicine|September 4, 2021
Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approachesIska Moxon-Emre, Christine Dahl, Vijay Ramaswamy, et al.
Cancer Medicine|September 4, 2021
Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinomaLisa P Spees, Stephanie B Wheeler, Bradford E Jackson, et al.
Pageof 913